MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹2,333 Cr | ₹2,516 Cr | ₹2,398 Cr | ₹1,671 Cr | ₹1,975 Cr |
What is the latest Profit Before Tax of MANKIND PHARMA ?
| Year | Profit Before Tax |
|---|---|
| Mar2026 | ₹2,333 Cr |
| Mar2025 | ₹2,516 Cr |
| Mar2024 | ₹2,398 Cr |
| Mar2023 | ₹1,671 Cr |
| Mar2022 | ₹1,975 Cr |
How is Profit Before Tax of MANKIND PHARMA Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,333 Cr | -7.30 | |
| Mar2025 | ₹2,516 Cr | 4.94 | |
| Mar2024 | ₹2,398 Cr | 43.48 | |
| Mar2023 | ₹1,671 Cr | -15.36 | |
| Mar2022 | ₹1,975 Cr | - | |
Compare Profit Before Tax of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹102,785.4 Cr | 8.1% | -2.2% | 1.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 8.1% |
-2.2% |
1.2% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses